版本:
中国

BRIEF-Novartis says FDA sets advisory committee meeting CTL019

June 6 Novartis Ag

* Says FDA sets advisory committee meeting on July 12 for CTL019 Car-T therapy for pediatric b-cell acute lymphoblastic leukemia

* FDA has previously granted priority review Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐